One of the first project i&i Prague participated in is Dracen Pharmaceuticals. Dracen itself started as an international science team at the Institute of Organic Chemistry and Biochemistry (IOCB Prague) and Johns Hopkins University (Baltimore, USA). The scientific team prepared and tested new substances for cancer treatment that are effective through stopping the metabolism of glutamine.
Founding of LAM-X, a.s., the newest company accelerated by i&i Prague and Charles University Innovations Prague, s.r.o. was met with both interest and positive feedback from Czech national media. Company was established on 20th January 2020 and since then 17 articles in the best and most read Czech media were published about it.
The LAM-X platform technology can be used in the fight against infections that are caused by surface–transmitted pathogens found in hospitals, sanitation facilities, food and water production factories. The lead product is a nanomembrane that generates singlet oxygen upon activation by visible light. This membrane can have a wide usage as preventive wound dressing which can help reduce amount of antibiotic resistence. The clinical study on patients suffering from ulcers proved the efficacy of the LAM-X membrane.
The list of media, where LAM-X was mentioned, is rather wide (dispclaimer: articles are mostly in Czech):
We are very proud that this technology was met with such and interest and we believe it will once again inform public about quality of Czech Science.
More about LAM-X technology and their products on: https://lam-x.tech/ or https://www.linkedin.com/company/lam-x/about/